---
title: "Golimumab - Psoriasis With Arthropathy"
sidebar: mydoc_sidebar
permalink: db06674-mesh-d015535-1.html
toc: false 
---


Path ID: `DB06674_MESH_D015535_1`
{% include image.html url="images/db06674-mesh-d015535-1.png" file="db06674-mesh-d015535-1.png" alt="db06674-mesh-d015535-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C529000">MESH:C529000 </a> | Golimumab | Drug |
| <a href="https://identifiers.org/UniProt:P01375">UniProt:P01375 </a> | Tumor necrosis factor | Protein |
| <a href="https://identifiers.org/reactome:R-HSA-75893">reactome:R-HSA-75893 </a> | TNF signaling | Pathway |
| <a href="https://identifiers.org/GO:0006954">GO:0006954 </a> | Inflammatory response | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D015535">MESH:D015535 </a> | Psoriasis with arthropathy | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Golimumab | DECREASES ACTIVITY OF | Tumor Necrosis Factor |
| Tumor Necrosis Factor | PARTICIPATES IN | Tnf Signaling |
| Tnf Signaling | POSITIVELY REGULATES | Inflammatory Response |
| Inflammatory Response | CAUSES | Psoriasis With Arthropathy |
|---------|-----------|---------|

Reference: 
  - [https://en.wikipedia.org/wiki/Psoriatic_arthritis](https://en.wikipedia.org/wiki/Psoriatic_arthritis)
  - [https://go.drugbank.com/drugs/DB06674](https://go.drugbank.com/drugs/DB06674)
